Exicure, Inc. (XCUR) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Exicure reported revenue of $0, down 100.0% from $500,000 the year before. Net income was -$4.9M, or -$0.79 per diluted share. Operating activities generated -$8.6M of cash, leaving -$8.6M of free cash flow. At fiscal year end, Exicure held $14.0M in total assets against $10.1M in total liabilities.
Open the full interactive Exicure financials → Quarterly statements, key ratios, valuation history and price charts.
Exicure Key Stats
| Share Price | $1.15 |
|---|---|
| Market Cap | $7.3M |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $1.00 – $7.29 |
| Shares Outstanding | 6.4 million (basic, 2026 Q2) |
Exicure Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $16.6M | -$483,000 | $28.8M | $0 | $500,000 | $0 |
| Operating Income | -$25.4M | -$62.5M | -$1.8M | -$15.0M | -$12.2M | -$4.2M |
| Pre-Tax Income | -$24.7M | -$64.1M | -$2.4M | -$16.9M | -$9.7M | -$5.6M |
| Income Tax | $0 | $0 | $209,000 | $0 | $8,000 | -$634,000 |
| Net Income | -$24.7M | -$64.1M | -$2.6M | -$16.9M | -$9.7M | -$4.9M |
| Diluted EPS | -$22.50 | -$108.00 | -$2.80 | -$10.55 | -$4.75 | -$0.79 |
Exicure Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$2.4M | -$2.9M | -$1.8M | -$1.1M |
| Diluted EPS | -$0.39 | -$0.46 | -$0.29 | -$0.18 |
Exicure Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $33.3M | $34.6M | $8.6M | $816,000 | — | — |
| Current Assets | $86.3M | $43.7M | $10.1M | $2.0M | $13.7M | $4.6M |
| Total Assets | $100.4M | $64.9M | $23.3M | $11.6M | $15.1M | $14.0M |
| Current Liabilities | $13.7M | $34.1M | $1.6M | $2.5M | $3.1M | $3.9M |
| Total Long-Term Debt | $16.6M | $13.7M | — | — | — | — |
| Total Liabilities | $38.9M | $53.6M | $8.4M | $8.5M | $8.3M | $10.1M |
| Shareholders' Equity | $61.5M | $11.2M | $14.9M | $3.0M | $6.8M | $3.9M |
Exicure Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$39.3M | -$34.8M | -$35.7M | -$10.4M | -$2.9M | -$8.6M |
| Cash From Investing | $10.1M | $43.1M | $4.7M | -$1.1M | $0 | -$1.8M |
| Cash From Financing | $15.1M | $1.1M | -$3.1M | $3.7M | $13.4M | $1.6M |
| Free Cash Flow | -$42.4M | -$35.8M | -$35.7M | -$10.4M | — | -$8.6M |
Figures from Exicure's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Exicure financials page for every line item.
Exicure Company Profile
| Ticker | XCUR |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Chicago, Illinois |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001698530 |
Frequently Asked Questions
What was Exicure's revenue in fiscal 2025?
Exicure (XCUR) reported revenue of $0 for fiscal 2025.
What is Exicure's annual revenue history?
Exicure's annual revenue by fiscal year: 2020: $16.6M; 2021: -$483,000; 2022: $28.8M; 2023: $0; 2024: $500,000; 2025: $0.
What was Exicure's net income in fiscal 2025?
Exicure reported net income of -$4.9M for fiscal 2025.
What was Exicure's earnings per share (EPS) in fiscal 2025?
Exicure's diluted EPS was -$0.79 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Exicure generate in fiscal 2025?
Exicure generated -$8.6M of free cash flow in fiscal 2025.
What was Exicure's revenue last quarter?
In its most recent reported quarter (2026 Q2), Exicure reported revenue of $0.
How many shares of Exicure are outstanding?
Exicure reported a weighted average of 6.4 million basic shares outstanding in 2026 Q2.
What is Exicure's market cap?
Based on its latest closing price, Exicure (XCUR) has a market capitalization of about $7.3M.
When does Exicure's fiscal year end?
Exicure's fiscal year end, as registered with the SEC, is December 31.
Where is Exicure headquartered?
Exicure lists its business address in Chicago, Illinois in its SEC filings.